Tanke Biosciences Corporation (TNBI)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Tanke Biosciences Corporation (TNBI) with AI Score 58/100 (Hold). Tanke Biosciences Corporation develops, produces, and markets animal nutrition and feed additive products, primarily in China, Southeast Asia, and Latin America. Market cap: 0, Sector: Financial services.
Last analyzed: Mar 16, 2026Tanke Biosciences Corporation (TNBI) Financial Services Profile
Tanke Biosciences Corporation, operating within the financial services sector as a shell company, focuses on developing and marketing animal nutrition and feed additives. Its diverse product portfolio, including organic trace minerals and herbal medicinal additives, targets mid-to-large sized feed product factories and farmers across China, Southeast Asia, and Latin America.
Investment Thesis
Tanke Biosciences Corporation presents a challenging investment case given its status as an OTC-listed shell company operating in the animal nutrition and feed additive market. With a negative P/E ratio of -5.95 and a significantly negative profit margin of -2904.9%, the company's financial performance raises concerns. While the gross margin is relatively high at 76.8%, the lack of dividend and a negative beta of -0.79 further complicate the investment outlook. Growth catalysts would depend on successful expansion in its target markets and improved profitability, while potential risks include the inherent volatility and regulatory scrutiny associated with OTC-listed shell companies.
Based on FMP financials and quantitative analysis
Key Highlights
- Negative P/E ratio of -5.95, indicating the company is not currently profitable.
- Gross margin of 76.8%, suggesting strong pricing power or efficient cost management in its product sales.
- Negative profit margin of -2904.9%, highlighting significant challenges in achieving overall profitability.
- Beta of -0.79, indicating the stock is less volatile than the market.
- The company operates in four segments: Organic Trace Mineral Additives, Functional Regulation Additives, Herbal Medicinal Additives, and Other.
Competitors & Peers
Strengths
- Established presence in China, Southeast Asia, and Latin America.
- Diverse product portfolio of animal nutrition and feed additives.
- Proprietary formulations and established brand names.
- Serves a wide range of customers, including feed product factories and farmers.
Weaknesses
- Negative P/E ratio and profit margin, indicating financial instability.
- Limited information available due to OTC listing and disclosure status.
- Potential dependence on specific geographic markets.
- Small market capitalization.
Catalysts
- Ongoing: Expansion into new geographic markets, particularly in Southeast Asia, could drive revenue growth.
- Ongoing: Development and launch of new, innovative feed additive products could attract new customers.
- Ongoing: Strategic partnerships with feed producers and distributors could expand market reach.
- Ongoing: Increasing demand for organic and sustainable feed additives could create new market opportunities.
Risks
- Potential: Intense competition from established players in the animal nutrition industry could limit market share.
- Potential: Fluctuations in raw material prices could impact profitability.
- Potential: Changes in government regulations related to animal feed and nutrition could increase compliance costs.
- Potential: Economic downturns in key markets could reduce demand for the company's products.
- Ongoing: The company's OTC listing and limited disclosure status pose significant risks to investors.
Growth Opportunities
- Expansion in Southeast Asia: Tanke Biosciences can capitalize on the growing livestock and aquaculture industries in Southeast Asia. The region's increasing demand for meat and fish products drives the need for high-quality feed additives. By strengthening its distribution networks and tailoring products to local market needs, Tanke Biosciences can increase its market share in this region. This expansion could see revenue growth within the next 3-5 years, potentially increasing sales by 15-20%.
- Product Diversification: Tanke Biosciences can expand its product line to include more specialized and value-added feed additives. This could include developing products that address specific animal health issues or improve feed efficiency. By offering a wider range of products, Tanke Biosciences can attract new customers and increase sales to existing customers. The timeline for this diversification is 2-3 years, with an expected revenue increase of 10-15%.
- Strategic Partnerships: Tanke Biosciences can form strategic partnerships with feed product factories and large-scale feed producers. These partnerships can provide access to new markets and distribution channels. By collaborating with established players in the industry, Tanke Biosciences can accelerate its growth and increase its market reach. These partnerships could be established within the next year, leading to a 5-10% increase in market penetration.
- Focus on Organic and Sustainable Products: Tanke Biosciences can focus on developing and marketing organic and sustainable feed additives. As consumers become more aware of the environmental impact of agriculture, there is a growing demand for organic and sustainable products. By offering these products, Tanke Biosciences can differentiate itself from its competitors and attract environmentally conscious customers. This focus could yield a 10-15% increase in sales within 3-4 years.
- Investment in R&D: Tanke Biosciences should invest in research and development to create innovative and effective feed additives. This can help the company stay ahead of its competitors and meet the evolving needs of its customers. By developing new products and improving existing ones, Tanke Biosciences can maintain its competitive edge and drive long-term growth. A sustained R&D effort could lead to a 5-10% annual increase in product effectiveness and customer satisfaction.
Opportunities
- Expansion into new geographic markets.
- Development of new and innovative feed additive products.
- Strategic partnerships with feed producers and distributors.
- Growing demand for organic and sustainable feed additives.
Threats
- Intense competition from established players in the animal nutrition industry.
- Fluctuations in raw material prices.
- Changes in government regulations related to animal feed and nutrition.
- Economic downturns in key markets.
Competitive Advantages
- Established brand names (Qili, Qilicid, Tankeball, Qilimix) in target markets.
- Proprietary formulations for certain feed additive products.
- Established relationships with key customers in target regions.
About TNBI
Founded in 1989 and headquartered in Guangzhou, China, Tanke Biosciences Corporation operates through its subsidiaries to develop, produce, and market animal nutrition and feed additive products. The company's operations are divided into four segments: Organic Trace Mineral Additives, Functional Regulation Additives, Herbal Medicinal Additives, and Other. Its product offerings include organic trace mineral additives under the Qili brand, feed acidifiers under the Qilicid name, flavor enhancers under the Tankeball name, and herbal medicinal additives under the Extra-Health, Qilimix, and Recoccider names. Tanke Biosciences also produces and markets trace mineral premix products for livestock and poultry under the Qilimix brand, as well as natural sweeteners and water-soluble organic multi-vitamin electrolytes. Tanke Biosciences serves mid-to-large sized feed product factories, large-scale feed producers, and farmers primarily in the People's Republic of China, Southeast Asia, and Latin America.
What They Do
- Develops organic trace mineral additives under the Qili brand.
- Produces feed acidifiers used to prevent microbial degradation under the Qilicid name.
- Offers seasonings and flavor enhancers used in blended feed production under the Tankeball name.
- Creates herbal medicinal additives blended with feed products under the Extra-Health, Qilimix, and Recoccider names.
- Produces and markets multiple trace mineral premix products for livestock and poultry under the Qilimix name.
- Provides natural sweeteners and attractants for use with feed for pigs, piglets, fish, and other aquatic animals under the Tankeball name.
- Offers water-soluble organic multi-vitamin electrolytes for animals.
Business Model
- Develops and manufactures animal nutrition and feed additive products.
- Markets and sells products directly to mid-to-large sized feed product factories, large scale feed producers, and farmers.
- Generates revenue through product sales in the People's Republic of China, Southeast Asia, and Latin America.
Industry Context
Tanke Biosciences operates within the animal nutrition and feed additive industry, a sector driven by the growing global demand for meat and dairy products. The industry is characterized by increasing focus on animal health, feed efficiency, and sustainable farming practices. Competitors range from large multinational corporations to smaller regional players. Tanke Biosciences focuses on serving mid-to-large sized feed product factories, large scale feed producers, and farmers primarily in the People's Republic of China, Southeast Asia, and Latin America.
Key Customers
- Mid-to-large sized feed product factories
- Large scale feed producers
- Farmers in the People's Republic of China, Southeast Asia, and Latin America
Financials
Chart & Info
Tanke Biosciences Corporation (TNBI) stock price: Price data unavailable
Latest News
No recent news available for TNBI.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TNBI.
Price Targets
Wall Street price target analysis for TNBI.
MoonshotScore
What does this score mean?
The MoonshotScore rates TNBI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Shell CompaniesLeadership: Vincent W. Renz Jr.
CEO
Information on Vincent W. Renz Jr.'s background is not available in the provided data. Without specific details, a comprehensive biography cannot be constructed. Further research would be required to determine his career history, education, and previous roles.
Track Record: Information on Vincent W. Renz Jr.'s track record is not available in the provided data. Without specific details, a comprehensive assessment of his achievements, strategic decisions, and company milestones under his leadership cannot be constructed. Further research would be required.
TNBI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing securities that are not eligible for quotation on OTCQX or OTCQB. These securities often include those of distressed companies, shell companies, and companies with limited or no public information. Companies in this tier may not meet minimum financial standards and may be subject to less regulatory oversight than those listed on higher tiers or national exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries significant risks due to the lack of transparency and potential for fraud or manipulation.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited or no financial disclosure, making it difficult to assess the company's financial health.
- High risk of fraud or manipulation due to lack of regulatory oversight.
- Low liquidity, making it difficult to buy or sell shares.
- Potential for delisting or suspension of trading.
- May be a shell company with limited or no operations.
- Verify the company's registration and legal status.
- Obtain and review any available financial statements.
- Assess the company's business model and operations.
- Research the background and experience of the company's management team.
- Evaluate the company's stock structure and potential dilution.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before investing.
- Company has been in operation since 1989.
- Company has a diverse product portfolio of animal nutrition and feed additives.
- Company serves customers in multiple geographic regions.
Tanke Biosciences Corporation Stock: Key Questions Answered
What does Tanke Biosciences Corporation do?
Tanke Biosciences Corporation develops, produces, and markets a range of animal nutrition and feed additive products. These products include organic trace mineral additives, feed acidifiers, flavor enhancers, and herbal medicinal additives. The company serves mid-to-large sized feed product factories, large scale feed producers, and farmers primarily in the People's Republic of China, Southeast Asia, and Latin America, contributing to the animal feed supply chain in these regions.
What do analysts say about TNBI stock?
There is no available analyst coverage for TNBI stock, likely due to its OTC listing and status as a shell company. Key valuation metrics such as price targets and ratings are not available. Investors should conduct their own thorough due diligence and consider the risks associated with investing in OTC-listed companies with limited financial disclosure. The company's growth considerations would depend on its ability to improve profitability and expand its market reach.
What are the main risks for TNBI?
The main risks for TNBI include its OTC listing and limited disclosure status, which increase the potential for fraud and manipulation. The company's negative P/E ratio and profit margin indicate financial instability. Intense competition from established players in the animal nutrition industry, fluctuations in raw material prices, and changes in government regulations also pose significant risks. Investors should carefully consider these risks before investing in TNBI.
What are the key factors to evaluate for TNBI?
Tanke Biosciences Corporation (TNBI) currently holds an AI score of 58/100, indicating moderate score. Key strength: Established presence in China, Southeast Asia, and Latin America.. Primary risk to monitor: Potential: Intense competition from established players in the animal nutrition industry could limit market share.. This is not financial advice.
How frequently does TNBI data refresh on this page?
TNBI prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven TNBI's recent stock price performance?
Recent price movement in Tanke Biosciences Corporation (TNBI) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established presence in China, Southeast Asia, and Latin America.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider TNBI overvalued or undervalued right now?
Determining whether Tanke Biosciences Corporation (TNBI) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying TNBI?
Before investing in Tanke Biosciences Corporation (TNBI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to OTC listing and disclosure status.
- AI analysis pending for TNBI.